 |
Available partnering opportunities include:
Commercialization and Development
- Prestara™ for systemic lupus erythematosus
- Marketing and development licenses available for Europe, Africa, Middle East and South America
Drug Discovery Research Collaborations
We are interested in collaborating with pharmaceutical and biotechnology companies with interests and capabilities complementary to ours.
Our current therapeutic target is the Hepatitis C Virus for preclinical
development and optimization against a variety of targets.
Technology Licenses
- Hepatitis E Virus
- Non-exclusive diagnostics licenses available
- All other applications, excluding vaccines, available
- Hepatitis G Virus
- All applications, excluding diagnostics, available
- Non-exclusive research licenses available to qualified research institutions
- DNA Amplification
- Linker Aided DNA Amplification (LADA): Licenses available for all applications
- Rapid Amplification of cDNA Ends (RACE): Licenses available for all applications
- DNA and RNA Binding
- Sequence-specific DNA-binding technology
- Methods for identifying sequence binding preference
- Methods for constructing compounds
- Methods for controlling gene expression
- Compositions of binding compounds
- DNA-binding compound mediated molecular switch system
- Promoters for regulated gene expressions
- dsRNA/dsRNA-binding protein methods and compositions
- Immunomodulatory Genes and Methods
- Human Rad50 Gene and methods of use
- Method of identifying activated T-cells
© Genelabs Technologies, Inc. All rights reserved. -
Terms of Use
|
|
